Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1484 participants.

Also called NCT07288749

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,484 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07288749
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07288749. Randomized; quadruple masking; primary purpose treatment. Start 2026-01-01 (anticipated); primary completion 2030-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.
Acronym
GLID-HF
Condition
Type 2 Diabetes Mellitus (T2DM)
Condition
Chronic Heart Failure (CHF)
Intervention (Drug)
Glimepiride (oral)
Intervention (Drug)
Placebo
Lead sponsor
Tongji Hospital (class: other)
Collaborator
Shanghai Zhongshan Hospital (class: other)
Collaborator
Nanjing Medical University (class: other)
Collaborator
Second Xiangya Hospital of Central South University (class: other)
Collaborator
Huaxi Hospital (class: other)
Collaborator
Zhongnan Hospital (class: other)
Collaborator
Xiangya Hospital (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)
Collaborator
The First Affiliated Hospital of Air Force Medical University (class: other)
Collaborator
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)
Collaborator
The First Affiliated Hospital of Zhengzhou University (class: other)
Collaborator
First Affiliated Hospital of Xinjiang Medical University (class: other)
Collaborator
Anhui Provincial Hospital (class: other government)
Collaborator
Southwest Medical University (class: other)
Collaborator
First Hospital of China Medical University (class: other)
Collaborator
Wuhan Central Hospital (class: other)
Collaborator
Tianjin Medical University (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 13

Record details

Record id
cardio:ct-nct07288749
Content hash
d88b43f5124c7ba633ec9d03276becc04b52094bc9fbbe53df64dd516f39c344